Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Debt / NOTE 1.500%10/1
-
Market price (% of par)
-
124.7%
-
Total 13F principal
-
$313,097,012
-
Principal change
-
+$11,217,999
-
Total reported market value
-
$391,105,519
-
Number of holders
-
41
-
Value change
-
+$16,672,390
-
Number of buys
-
20
-
Number of sells
-
18
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q3 2016
As of 30 Sep 2016,
BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 was held by
41 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$313,097,012
in principal (par value) of the bond.
The largest 10 bondholders included
Invesco Ltd., FRANKLIN RESOURCES INC, ADVENT CAPITAL MANAGEMENT /DE/, LINDEN ADVISORS LP, FMR LLC, CALAMOS ADVISORS LLC, Allianz Asset Management GmbH, ROYAL BANK OF CANADA, LAZARD ASSET MANAGEMENT LLC, and SHENKMAN CAPITAL MANAGEMENT INC.
This page lists
41
institutional bondholders reporting positions
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.